HydrALAZINE Hydrochloride tablets recalled for failed purity and degradation specifications
SKY PACKAGING is recalling HydrALAZINE Hydrochloride 50mg tablets nationwide due to failed impurities and degradation specifications. Four affected lot numbers have expiration dates from April 2025 to February 2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for failed drug purity and degradation specifications. No illnesses or injuries are reported in the source. Per the rubric, risk-of-harm products without reported injury warrant a maximum score of 3 (High).
Plain-English summary
HydrALAZINE Hydrochloride 50mg tablets are being recalled nationwide due to failed impurities and degradation specifications. The affected product was manufactured by Strides Pharma Science Ltd in Bengaluru, India, and distributed by SKY PACKAGING (McKesson Corporation) in Tennessee.
Four specific lot numbers are affected by this Class II recall, with expiration dates ranging from April 30, 2025 to February 28, 2026. The affected lot numbers are: 0000127410 (expires April 30, 2025), 0000127579 (expires August 31, 2025), 0000128245 (expires December 31, 2025), and 0000128486 (expires February 28, 2026). The product carries NDC 63739-328-10.
Patients with affected batches should contact their pharmacist or healthcare provider immediately for guidance.
The recalled product
- Product
- HydrALAZINE Hydrochloride, 100 Tablets (10x10), USP, 50mg, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-328-10
- Manufacturer
- SKY PACKAGING
- Category
- Drug
- Hazard
- impurities
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: 0000127410
- 63739-328-10
- Exp. Date 30-Apr-2025
- 0000127579
- Exp. Date 31-Aug-2025
- 0000128245
- Exp. Date 31-Dec-2025
- 0000128486
- Exp. Date 28-Feb-2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27